(Q47683391)

4 February 2018

title

Comparison of the LiPA HIV-1 RT test, selective PCR and direct solid phase sequencing for the detection of HIV-1 drug resistance mutations (English)

1 reference

4 February 2018

author

Kristel Van Laethem

4

1 reference

4 February 2018

Anne-Mieke Vandamme

11

1 reference

4 February 2018

Bonaventura Clotet Sala

10

object named as

Clotet B

1 reference

4 February 2018

author name string

Schmit JC

1

1 reference

4 February 2018

Ruiz L

2

1 reference

4 February 2018

Stuyver L

3

1 reference

4 February 2018

Vanderlinden I

5

1 reference

4 February 2018

Puig T

6

1 reference

4 February 2018

Rossau R

7

1 reference

4 February 2018

Desmyter J

8

1 reference

4 February 2018

De Clercq E

9

1 reference

4 February 2018

publication date

1 July 1998

1 reference

4 February 2018

Journal of Virological Methods

published in

1 reference

4 February 2018

volume

73

1 reference

4 February 2018

issue

1

1 reference

4 February 2018

page(s)

77-82

1 reference

4 February 2018

Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900043-3

7 January 2021

A microtitre format point mutation assay: application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900043-3

7 January 2021

Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900043-3

7 January 2021

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900043-3

7 January 2021

Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900043-3

7 January 2021

Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddC

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900043-3

7 January 2021

Multiple drug resistance to nucleoside analogues and nonnucleoside reverse transcriptase inhibitors in an efficiently replicating human immunodeficiency virus type 1 patient strain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900043-3

7 January 2021

Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900043-3

7 January 2021

Functional characterization of RNA-dependent DNA polymerase and RNase H activities of a recombinant HIV reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900043-3

7 January 2021

Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2898%2900043-3

7 January 2021

10.1016/S0166-0934(98)00043-3

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

9705178

1 reference

4 February 2018